west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "HAO Yu" 3 results
  • Analysis of clinical features of non-epileptic psychotic seizures in Tibetan population

    ObjectiveTo analyze the clinical features of psychogenic non-epileptic seizures (Psychogenic nonepileptic seizures, PNES) in Tibetan population in Tibet, so as to help clinicians identify the disease.MethodsRetrospective analyzed the clinical data of patients with PNES in the Department of Neurology, People's Hospital of Tibet Autonomous Region from June 2016 to December 2018.ResultsIn general clinical data, there were significant differences between male and female patients in the results of video electroencephalogram (EEG) monitoring the non-epileptic seizures (P< 0.05). There were no significant differences in mean age, mean onset time, family history of epilepsy, head injury and marital status between male and female patients (P> 0.05). There was no significant difference in symptoms between male and female, but there were differences among different age groups (P> 0.05). In the onset age, the main manifestation was young women, but there was no significant difference in the onset of PNES among different age groups.ConclusionsThere was significant differences between male and female PNES petients, but no significant differences in onset time, marriage and family history of epilepsy between the male and female patients with PNES in Tibet. The clinical manifestations of PNES were different in different ages of patients in Tibet.

    Release date:2020-01-09 08:49 Export PDF Favorites Scan
  • The clinical characteristics of epilepsy patients treated with multi-drug combination therapy in Tibet plateau area

    Objective To explore the clinical characteristics of patients with combined use of ≥2 kinds of anti-seizure medications in Tibetan plateau. Methods Epilepsy patients who were hospitalized in the People’s Hospital of Tibet Autonomous Region from September 2018 to September 2023 and used ≥2 kinds of anti-seizure medications in combination were selected. Their demographic data such as gender, age, and ethnicity, as well as diagnostic information, medication and other clinical data were collected, and relevant demographic and clinical characteristics were analyzed. In the later stage, telephone follow-up was used to record medication and epileptic seizure control. Results A total of 2295 patients with epilepsy were included, of which 142 (6.2%) met the inclusion criteria, of which 133 (93.7%) were Tibetans. There were more males than females (86 vs. 56, P<0.05), and more minors and young patients than middle-aged and elderly patients (106 vs. 36, P<0.05). 87.3% of the patients underwent magnetic resonance imaging (MRI) or computed tomography (CT), and 71.1% of the patients were abnormal. The main cause of epilepsy was structural etiology (84/142, 59.2%). The most common combination was two drugs (127/142, 89.4%). The largest proportion of combination was sodium valproate and levetiracetam (46/142, 32.4%). After standardized multi-drug combination therapy, the average frequency of epilepsy seizures was significantly reduced compared with the baseline, and the difference was statistically significant (P<0.05). Among the 98 patients aged ≥14 years, 15 cases (15.3%) had drug-refractory epilepsy, 18 cases (18.4%) had seizures controlled by standardized combination medication, 16 cases (16.3%) had seizures controlled by reducing combination medication to a single drug, 5 cases (5.1%) had good control and had stopped medication, 3 cases (3.1%) had frequent epileptic seizures due to poor medication compliance, 15 cases (15.3%) had irregular medication, 17 cases (17.3%) died, and 9 cases (9.2%) were lost. Conclusion The proportion of epilepsy treated with multiple drugs and refractory to drugs was lower than the conclusion of previous studies, and the anti-epileptic effect of multiple drugs was positive. Structural causes (stroke, etc.) are the main causes of epilepsy, and brain parasitic infection is a unique factor of high-altitude epilepsy. Strengthening the standardized use of drugs will help improve the treatment status and prognosis of patients.

    Release date:2024-11-20 10:50 Export PDF Favorites Scan
  • Development of a prediction model of absolute risk for breast cancer

    ObjectivesTo explore the construction method of prediction model of absolute risk for breast cancer and provide personalized breast cancer management strategies based on the results.MethodsA case-control design was conducted with 2 747 individuals diagnosed as primary breast cancer by pathology in West China Hospital of Sichuan University from 2000 to 2017 and 6 307 healthy controls from Breast Cancer Screening Cohort in Sichuan Women and Children Center and Chengdu Shuangliu District Maternal and Child Health Hospital. Standardized questionnaires and information management systems in hospital were used to collect information. Decision trees, logistic regression, the formula in Gail model and registration data in China were used to estimate the probability of 5-year risk of breast cancer. Eventually a ROC (receiver operating characteristics) curve was drawn to identify optimal cut-off value, and the power was evaluated.ResultsThe decision tree exported 4 variables, which were urban or rural sources, number of live birth, age and age at menarche. The median 5-year risk and interquartile range of the controls was 0.027% and 0.137%, while the median 5-year risk and interquartile range of the cases was 0.219% and 0.256%. The ROC curve showed the cut-off value was 0.100%. Through verification, the sensitivity was 0.79, the specificity was 0.73, the accuracy was 0.75, and the AUC (area under the curve) was 0.79.ConclusionsThe methods used in our study based on 9 054 female individuals in Sichuan province could be used to predict the 5-year risk for breast cancer. Predictor variables include urban or rural sources, number of live birth, age, and age at menarche. If the 5-year risk is more than 0.100%, the person will be judged as a high risk individual.

    Release date:2020-01-14 05:25 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content